Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. dr. Jan De Bleecker

Work address: C. Heymanslaan 10, ingang 12 - verdieping 12
9000 Gent
Email: Jan.DeBleecker@UGent.be
ORCID iD: 0000-0002-1328-1812

Show Sort by

Add to list
- Journal Article
- open access
hATTR-polyneuropathie: Diagnose en behandeling

Jan De Bleecker (UGent) and Elke De Vos (UGent)

(2022) De Specialist. 190. p.14-15
Add to list
Clinical features of extra-muscular disease in dermatomyositis and anti-synthetase syndrome patients with skin involvement classified by presence of disease-specific autoantibodies : results from the EuroMyositis registry

Ryan M Hum, James B Lilleker, Janine A Lamb, William E Ollier, Guochung Wang, Lucy R Wedderburn, Louise P Diederichsen, Jens Schmidt, Paula Oakley, Olivier Benveniste, et al.

(2022) RHEUMATOLOGY. In Rheumatology 61(S1). p.i124-i125
Add to list
- Conference Paper
- open access
Osmotic stress-associated sodium/myo-inositol co-transporter is upregulated in skeletal muscle of the mdx mouse

Caroline Merckx (UGent) , Gwenny Cosemans (UGent) , Jana Zschuentzsch, Jens Schmidt, Jan De Bleecker (UGent) and Boel De Paepe (UGent)

(2022)
Add to list
- Journal Article
- A1
- open access
Description of osmolyte pathways in maturing mdx mice reveals altered levels of taurine and sodium/myo-inositol co-transporters

Caroline Merckx (UGent) , Gwenny Cosemans (UGent) , Jana Zschüntzsch, Robrecht Raedt (UGent) , Jens Schmidt, Boel De Paepe (UGent) and Jan De Bleecker (UGent)

(2022) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 23(6).
Add to list
- Journal Article
- A2
- open access
An exploratory study of circulating cytokines and chemokines in patients with muscle disorders proposes CD40L and CCL5 represent general disease markers while CXCL10 differentiates between patients with an autoimmune myositis

Boel De Paepe (UGent) , Ken Bracke (UGent) and Jan De Bleecker (UGent)

(2022) CYTOKINE. X. 4(1).
Add to list
Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study) : a randomised, double-blind, placebo-controlled phase 3 trial

Merit Cudkowicz, Angela Genge, Nicholas Maragakis, Susanne Petri, Leonard van den Berg, Valtteri V Aho, Toni Sarapohja, Mikko Kuoppamäki, Chris Garratt, Ammar Al-Chalabi, et al.

(2021) LANCET NEUROLOGY. 20(10). p.821-831
Add to list
- Conference Paper
- C3
Myositis-specific and myositis-associated autoantibodies predict trajectories of damage over time in idiopathic inflammatory myopathies

F Espinosa-Ortega, M Holmqvist, K Lodin, M Dastmalchi, MG Danieli, J Venkovsky, J Knitza, S Oliveira, LP Diederichsen, L Wedderburn, et al.

(2021) SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. In Scandinavian Journal of Rheumatology 50(Supplement 130). p.49-50
Add to list
- Conference Paper
- C3
Genotype-phenotype correlations in VCP disease : results of an international multicentric study (The VCP study group)

M Schiava, C Ikenaga, T Stojkovic, M Caballero, I Nishino, B Velez Gomez, A Alonso Jimenez, A Kostera-Pruszczyk, F Miralles Morell, Jan De Bleecker (UGent) , et al.

(2021) EUROPEAN JOURNAL OF NEUROLOGY. In European Journal of Neurology 28(S1). p.190-191
Add to list
- Conference Paper
- C3
Extensive genetic and phenotypic description of MAPT p.R406W in the Flanders-Belgian population

H Gossye, S Van Mossevelde, J Van der Zee, Y Vermeiren, N De Roeck, A Sieben, Jan De Bleecker (UGent) , P De Deyn, P Cras, S Engelborghs, et al.

(2021) EUROPEAN JOURNAL OF NEUROLOGY. In European Journal of Neurology 28(S1). p.94-95
Add to list
- Conference Paper
- C3
In-depth phenotypic description of TBK1 mutations ; a frequent cause of FTD and ALS in the Flanders-Belgian population

H Gossye, S Van Mossevelde, J Van der Zee, Y Vermeiren, N De Roeck, Jan De Bleecker (UGent) , P Cras, P De Deyn, S Engelborghs, Tim Van Langenhove (UGent) , et al.

(2021) EUROPEAN JOURNAL OF NEUROLOGY. In European Journal of Neurology 28(S1). p.93-94

1
2
3
4
…
36
37

Next →